Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1 + rV270

Vaccine

Volumn 28, Issue 6, 2010, Pages 1655-1660

  Qi, Zhizhen ^a   Zhou, Lei ^b   Zhang, Qingwen ^a   Ren, Lingling ^a   Dai, Ruixia ^a   Wu, Benchuan ^c   Wang, Tang ^b   Zhu, Ziwen ^b   Yang, Yonghai ^a   Cui, Baizhong ^a   Wang, Zuyun ^a   Wang, Hu ^a   Qiu, Yefeng ^b   Guo, Zhaobiao ^b   Yang, Ruifu ^b   Wang, Xiaoyi ^b  

^a Qinghai Institute for Endemic Disease Prevention and Control of Qinghai Province   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c Beijing Institute of Bioengneering   (China)

Author keywords

F1 antigen; Protection; rV270 antigen; Yersinia pestis

Indexed keywords

EV76 VACCINE; IMMUNOGLOBULIN G; PLAGUE VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GUINEA PIG; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; YERSINIA PESTIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; GUINEA PIGS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PLAGUE; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEINS; RABBITS; SURVIVAL ANALYSIS; VACCINES, ATTENUATED; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 75249090550     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.078     Document Type: Article

References (53)

1. Perry R.D., and Fetherston J.D. Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 10 1 (1997) 35-66
2. Riedel S. Plague: from natural disease to bioterrorism. Proc (Bayl Univ Med Cent) 18 2 (2005) 116-124
3. Russell P., Eley S.M., Hibbs S.E., Manchee R.J., Stagg A.J., and Titball R.W. A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13 16 (1995) 1551-1556
4. Tripathi V., Chitralekha K.T., Bakshi A.R., Tomar D., Deshmukh R.A., Baig M.A., et al. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery. Vaccine 24 16 (2006) 3279-3289
5. Morton M., Garmory H.S., Perkins S.D., O'Dowd A.M., Griffin K.F., Turner A.K., et al. A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice. Vaccine 22 20 (2004) 2524-2532
6. Williamson E.D., Eley S.M., Griffin K.F., Green M., Russell P., Leary S.E., et al. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol 12 3-4 (1995) 223-230
7. Wang S., Heilman D., Liu F., Giehl T., Joshi S., Huang X., et al. A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague. Vaccine 22 25-26 (2004) 3348-3357
8. Garmory H.S., Freeman D., Brown K.A., and Titball R.W. Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen. Vaccine 22 8 (2004) 947-957
9. Grosfeld H., Cohen S., Bino T., Flashner Y., Ber R., Mamroud E., et al. Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen. Infect Immun 71 1 (2003) 374-383
10. Wessels JGaS. Ensuring safety of DNA vaccines. Microbial Cell Factories 4 26 (2005) 1-5
11. Titball R.W., and Williamson E.D. Yersinia pestis (plague) vaccines. Expert Opin Biol Ther 4 6 (2004) 965-973
12. Sabhnani L., and Rao D.N. Identification of immunodominant epitope of F1 antigen of Yersinia pestis. FEMS Immunol Med Microbiol 27 2 (2000) 155-162
13. Blisnick T., Ave P., Huerre M., Carniel E., and Demeure C.E. Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain. Infect Immun 76 8 (2008) 3808-3816
14. Glynn A., Freytag L.C., and Clements J.D. Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens. Vaccine 23 16 (2005) 1957-1965
15. Griffin K., Bedford R., Townson K., Phillpotts R., Funnell S., Morton M., et al. Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine. FEMS Immunol Med Microbiol 43 3 (2005) 425-430
16. Eyles J.E., Williamson E.D., Spiers I.D., and Alpar H.O. Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy. Vaccine 18 28 (2000) 3266-3271
17. Glynn A., Roy C.J., Powell B.S., Adamovicz J.J., Freytag L.C., and Clements J.D. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens. Infect Immun 73 8 (2005) 5256-5261
18. Reed D.S., and Martinez M.J. Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague. Vaccine 24 13 (2006) 2283-2289
19. Goodin J.L., Nellis D.F., Powell B.S., Vyas V.V., Enama J.T., Wang L.C., et al. Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague. Protein Expr Purif 53 1 (2007) 63-79
20. Jones S.M., Day F., Stagg A.J., and Williamson E.D. Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine 19 2-3 (2000) 358-366
21. Jones T., Adamovicz J.J., Cyr S.L., Bolt C.R., Bellerose N., Pitt L.M., et al. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection. Vaccine 24 10 (2006) 1625-1632
22. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., and Titball R.W. A single dose sub-unit vaccine protects against pneumonic plague. Vaccine 19 4-5 (2000) 566-571
23. Williamson E.D., Stagg A.J., Eley S.M., Taylor R., Green M., Jones S.M., et al. Kinetics of the immune response to the (F1 + V) vaccine in models of bubonic and pneumonic plague. Vaccine 25 6 (2007) 1142-1148
24. Jones S.M., Griffin K.F., Hodgson I., and Williamson E.D. Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine 21 25-26 (2003) 3912-3918
25. Smiley S.T. Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines 7 2 (2008) 209-221
26. Smiley S.T. Immune defense against pneumonic plague. Immunol Rev 225 (2008) 256-271
27. Une T., and Brubaker R.R. Roles of V antigen in promoting virulence and immunity in yersiniae. J Immunol 133 4 (1984) 2226-2230
28. Nakajima R., and Brubaker R.R. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun 61 1 (1993) 23-31
29. Nakajima R., Motin V.L., and Brubaker R.R. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun 63 8 (1995) 3021-3029
30. Nedialkov Y.A., Motin V.L., and Brubaker R.R. Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect Immun 65 4 (1997) 1196-1203
31. Overheim K.A., Depaolo R.W., Debord K.L., Morrin E.M., Anderson D.M., Green N.M., et al. LcrV plague vaccine with altered immunomodulatory properties. Infect Immun 73 8 (2005) 5152-5159
32. Wang Tang Q.Z., Wu B., Zhu Z., Yang Y., Cui B., Dai R., Zhang Q., Qiou Y., Wang Z., Wang H., Guo Z., Yang R., and Wang XiaoYi. Cloning and expression of Yersinia pestis rV270 antigen and efficacy against Y. pestis virμlent strain challenge. Lett Biotechnol 19 5 (2008) 663-666
33. Wang T., Qi Z., Wu B., Zhu Z., Yang Y., Cui B., et al. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge. Protein Expr Purif 61 1 (2008) 7-12
34. Rasoamanana B., Leroy F., Boisier P., Rasolomaharo M., Buchy P., Carniel E., et al. Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar. Clin Diagn Lab Immunol 4 5 (1997) 587-591
35. Hiroko Shibata S.N., Tadanori M., and Yasuo T. Development of novel drug delivery system (DDS) technologies for proteomic-based drug development. Biol Pharm Bull 27 10 (2004) 1483-1488
36. Bali Pulendran R.A. Translating innate immunity into immunological memory: implications for vaccine development. Cell 124 (2006) 849-863
37. Manuel Campos D.L.G. The effectiveness and limitations of immune memory: understanding protective immune responses. Int J Parasitol 33 (2003) 655-661
38. Christine Bourgeois C.T. CD4 T cells are required for CD8 T cell memory generation. Eur J Immunol 33 (2003) 3225-3231
39. Williamson E.D., Vesey P.M., Gillhespy K.J., Eley S.M., Green M., and Titball R.W. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin Exp Immunol 116 1 (1999) 107-114
40. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., and Titball R.W. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine 15 10 (1997) 1079-1084
41. Parent M.A., Berggren K.N., Kummer L.W., Wilhelm L.B., Szaba F.M., Mullarky I.K., et al. Cell-mediated protection against pulmonary Yersinia pestis infection. Infect Immun 73 11 (2005) 7304-7310
42. Philipovskiy A.V., and Smiley S.T. Vaccination with Live Yersinia pestis Primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Infect Immun 75 2 (2007) 878-885
43. Matson J.S., Durick K.A., Bradley D.S., and Nilles M.L. Immunization of mice with YscF provides protection from Yersinia pestis infections. BMC Microbiol 5 1 (2005) 38
44. Swietnicki W., Powell B.S., and Goodin J. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague. Protein Expr Purif 42 1 (2005) 166-172
45. Andrews G.P., Strachan S.T., Benner G.E., Sample A.K., Anderson Jr. G.W., Adamovicz J.J., et al. Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect Immun 67 3 (1999) 1533-1537
46. Benner G.E., Andrews G.P., Byrne W.R., Strachan S.D., Sample A.K., Heath D.G., et al. Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice. Infect Immun 67 4 (1999) 1922-1928
47. Ivanov M.I., Noel B.L., Rampersaud R., Mena P., Benach J.L., and Bliska J.B. Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis. Infect Immun (2008)
48. Do Y., Park C.G., Kang Y.S., Park S.H., Lynch R.M., Lee H., et al. Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells. Eur J Immunol 38 1 (2008) 20-29
49. DeBord K.L., Anderson D.M., Marketon M.M., Overheim K.A., DePaolo R.W., Ciletti N.A., et al. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun 74 8 (2006) 4910-4914
50. Williamson E.D., Flick-Smith H.C., Lebutt C., Rowland C.A., Jones S.M., Waters E.L., et al. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect Immun 73 6 (2005) 3598-3608
51. Williamson E.D., Flick-Smith H.C., Waters E., Miller J., Hodgson I., Le Butt C.S., et al. Immunogenicity of the rF1 + rV vaccine for plague with identification of potential immune correlates. Microb Pathog 42 1 (2007) 11-21
52. Blisnick T., Ave P., Huerre M., Carniel E., and Demeure C.E. Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis. Infect Immun (2008)
53. Santi L., Giritch A., Roy C.J., Marillonnet S., Klimyuk V., Gleba Y., et al. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc Natl Acad Sci USA 103 4 (2006) 861-866